In adult animals treatment with androgenic or oestrogenic hormones results in a temporary suppression of fertility after which there is a return to normal reproductive function. A different response, however, is seen in animals treated shortly after birth. Administration of steroid hormones within the first few days of life results in permanent sterility: a single subcutaneous injection of testosterone propionate given to female mice (Barraclough & Leathem 1954) or rats (Barraclough 1961 ) within ten days of birth produces in the adult animals failure to form corpora lutea and constantly cornified vaginal epithelium. Administration of cestradiol benzoate to neonatal males under similar conditions will evoke irreversible changes manifested by azospermia and decreased testicular androgen production (Kincl et al. 1963) . Female animals may be also permanently sterilized by various oestrogens, whereas males are insensitive to androgen treatment (Kincl, Folch Pi, Maqueo, Herrera Lasso, Oriol & Dorfman 1965) . Table 1 shows the effect seen at autopsy at the age of 45 days following several phenolic steroids given in a single injection to 5-day-old rats. In males the effect was judged on the basis of testicular and accessory sex tissue atrophy and on histological evaluation (Maqueo & Kincl 1964) . In females the presence or absence of corpora lutea was the main index used.
These data demonstrate that the activity of phenolic steroids in the neonatal rats is independent of their oestrogenic activity, as determined by uterine weight increase in the immature mouse assay (Rubin et al. 1951) , and constitutes an independent biological phenomenon. It has been postulated that the deleterious effect of steroid hormones in the neonatal female may be due to damage of those hypothalamic centres which in later life are destined to control ovulation (Harris 1964) . Our own data appear to cast some doubt on this hypothesis.
We have observed that a suspension of thymic cells injected before steroid treatment prevents subsequent sterility ). Since there is at present no evidence which would indicate a relationship between the thymus and the central nervous system perhaps other explanations should be considered. We visualize as one possibility the presence of high steroid levels during the early period of life producing disturbances in the development of the immunological system. This may lead to a state which is reflected at the time of sexual maturation in disturbances of the hypothalamic-hypophyseal-gonadal axis.
It has recently been reported that testosterone propionate injected directly into rat foetuses in utero produces sterility in females when they reach maturity (Swanson & van der Werff ten Bosch 1965). Since progesterone provides a protection in neonatal rats against this deleterious effect of the steroid ) some human hypogonadal states might be explained by decreased progesterone synthesis during pregnancy or by enzymatic abnormalities in the fcetalplacental unit permitting the presence of large amounts of androgens and/or cestrogens in the feetus. 
Glucagon Assays -A Summary ofthe Clinical and Physiological Findings
Literature on the physiological and clinical applications of glucagon immunoassay includes the body of work by Unger and his associates (Unger & Eisentraut 1965 , Unger et al. 1966 ) and only one other paper (Samols, Tyler, Marri & Marks 1965, and one abstract (Lawrence 1965) .
In dogs Unger found a higher concentration of immunochemical glucagon in pancreaticoduodenal venous plasma than in inferior vena caval plasma, consistent with pancreatic secretion of glucagon. Fasting canine pancreaticoduodenal venous glucagon was increased in dogs with chronic hypoglyc.vmia induced by phlorizin. Dogs made acutely hypoglycemic by the injection of insulin generally showed a gradual rise in pancreatic venous glucagon secretion. In man total starvation for three days was associated with a decrease in blood sugar levels and a three fold rise in mean peripheral venous glucagon concentration. When pancreaticoduodenal hyperglucagonemia was induced in dogs by insulin or phlorizin, the high glucagon levels were suppressed by the rapid intravenous administration of 25 g glucose. In man there was a suggestion of a fall in peripheral venous glucagon concentration 40-240 minutes after the ingestion of 100 g glucose. When peripheral venous hyperglucagonemia was induced by three days' starvation this hyperglucagonmmia appeared to be less readily suppressed by glucose loading than occurs normally.
Unger concluded that glucagon secretion rises during all forms of glucose need; the rise is suppressed by glucose refeeding. This favours the concept of glucagon as a hormone of glucose need, the function of which is to maximize hepatic glucose production when food is not available, thereby serving to maintain the flow of glucose to the brain.
In reviewing the remaining work on glucagon some dissimilarties appear. Samols, Tyler, Marri & Marks (1965) reported that in 20 nondiabetic control subjects venous plasma glucagon levels after an overnight fast ranged from 0-7 to 5 0 miug/ml (mean 2-4 mpg/ml), almost ten times higher than Unger's values. Similar high fasting values were recently described by Lawrence (1965) . Immunochemical support for our fasting endogenous glucagon values was obtained by testing the degree of cross-reaction between human endogenous glucagon and beef-pork glucagon, by comparing serial plasma dilutions (1: 48 to 1: 2) with the standard curve for exogenous glucagon. As several plasma dilutions yielded the same glucagon values in undiluted plasma, endogenous glucagon and beef-pork glucagon cross-reacted similarly. Since we have observed that the 4 for disappearance of exogenous glucagon was 10-15 minutes after the cessatioh of prolonged constant infusions of exogenous glucagon, and assuming the same rate of disappearance of endogenous glucagon, according to our results the secretion rate for endogenous glucagon in man in the fasting state can be calculated to be 50-200 pg/hour.
